Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SOAT1 | P35610 | 10/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6153447 | 0.95 | SOAT1 (0.71) | SOAT1 | |
| SCHEMBL6153954 | 0.94 | SOAT1 (0.71) | SOAT1 | |
| SCHEMBL6154191 | 0.93 | SOAT1 (0.70) | SOAT1 | |
| SCHEMBL6153254 | 0.93 | SOAT1 (0.72) | SOAT1 | |
| SCHEMBL6152616 | 0.93 | SOAT1 (0.78) | SOAT1 | |
| SCHEMBL6153328 | 0.92 | SOAT1 (0.71) | SOAT1 | |
| SCHEMBL6153031 | 0.89 | SOAT1 (0.76) | SOAT1 | |
| SCHEMBL6153550 | 0.85 | SOAT1 (0.78) | SOAT1 | |
| SCHEMBL6153561 | 0.85 | SOAT1 (0.61) | SOAT1 | |
| SCHEMBL6155124 | 0.84 | SOAT1 (1.00) | SOAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050165057-A1 | Novel piperidine derivative | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2005-07-28 | — | — | US | disclosed |
| EP-1500648-A1 | NOVEL PIPERIDINE DERIVATIVE | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 2005-01-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050165057-A1 | Novel piperidine derivative | ACAT2, ACAT1, LCAT | SOAT1 19/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.